The FDA has cleared a phase 3 trial for lacutamab in CTCL, following promising phase 2 results showing durable activity and safety. TELLOMAK 3 will assess progression-free survival with two cohorts: ...
During a live event, Thomas G. Martin, MD, discussed updated findings from the CARTITUDE-1 trial of cilta-cel and what they signify for patients with no disease progression at 5 years.
After receiving a rare cancer diagnosis for their one-year-old son, a New Castle family was able to receive treatment because ...
Republican National Committee Chair Ronna McDaniel and former Democratic National Committee Chair Donna Brazile joined h… Senator John Curtis (R-UT) and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback